Fitbit, Inc. (FIT - Free Report) reported first-quarter 2018 adjusted loss of 17 cents per share, lower than the Zacks Consensus Estimate of a loss of 20 cents. The top-line figure also exceeded the Zacks Consensus Estimate by 2 million.
The first-quarter results were impacted by weak demand for the company’s health and fitness trackers. Also, increasing competition from Apple, Samsung Electronics, Xiaomi and Garmin impacted its results.
Following the weaker-than-expected results in the first quarter, Fitbit’s share price plunged 5.45% in after-hours trading. Also, weak revenue guidance for the second quarter could be a reason for the plunge in share price.
In the quarter, Fitbit sold 2.2 million devices, down sequentially. New products launched in the last 12 months, namely Fitbit Ionic, Fitbit Versa, and Fitbit Aria 2 and accessory Fitbit Flyer, contributed 34% to revenues.
Management expects the newly launched Versa smartwatch to pick up demand more than its Ionic device. Also, the company plans to ramp up manufacturing capacity to meet expected higher demand for its smartwatches.
We, however, note that Fitbit’s growth has been hampered by the popularity of smartwatches in the fitness wearable category, influx of new wearables, increasing competition from Apple, lack of upgrades among existing users and lackluster growth in the Asia-Pacific region.
The impact of these headwinds has been significant on the stock, which has significantly underperformed the industry in the last 12 months. While the industry has gained 30%, the stock has lost 4.4%.
Let’s check out the numbers in detail.
Fitbit reported revenues of $247.9 million, down 17.1% year over year and 56.6% on a sequential basis. However, the top line was within management’s guidance of $240-$255 and above the consensus mark of $246 million.
Weakness in almost all regions led to the sequential decrease in revenues.
The average selling price (ASP) increased 10% sequentially and 16% from the prior-year quarter to $112 per device in the first quarter.
Geographically, revenues from the United States accounted for 56% of first-quarter revenues, EMEA brought in 26%, Americas excluding the United States contributed 7% and the remaining 11% came from the Asia Pacific.
On a sequential basis, all the regions depicted a decrease. However, on a year-over-year basis, revenues from the Asia Pacific increased 28%, while the same from all other regions decreased.
Margins and Net Income
Non-GAAP gross profit in the first quarter was $116.7 million. Gross margin was 47.1%, up 710 basis points (bps) year over year and 290 bps sequentially.
Non-GAAP operating expenses were 173.9 million versus 181.6 million in the year-ago quarter.
Pro-forma net loss was $41.0 million or loss per share was 17 cents compared with net loss of $34.4 million or loss per share of 15 cents in the year-ago period.
Balance Sheet and Cash Flow
In the first quarter, cash and cash equivalents were $378.4 million compared with $342 million in the fourth quarter.
Accounts receivables were $214.4 million compared with $406 million in the last reported quarter. Inventories were $145.4 million compared with $123.9 million in the fourth quarter.
Cash flow from operations was $10.2 million and free cash flow was ($2.5) million in the first quarter.
For the second quarter of 2018, Fitbit expects revenues in the range of $275-$295 million, representing a decline of approximately 19% year over year. The Zacks Consensus Estimate is pegged at $307.4 million.
The company expects non-GAAP loss per share within the range of 27-23 cents. The Zacks Consensus Estimate is pegged at a loss of 10 cents per share. It expects non-GAAP tax rate to be approximately 25%.
For full-year 2018, Fitbit reiterated its revenues of $1.5 billion. The Zacks Consensus Estimate for revenues is pegged at $1.47 billion.
Zacks Rank and Stocks to Consider
Fitbit has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the technology sector are SMC Corporation (SMCAY - Free Report) , Etsy, Inc. (ETSY - Free Report) and Littelfuse, Inc. (LFUS - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Long-term earnings per share growth rate for SMC Corporation, Etsy and Littelfuse is projected at 13.7%, 17.3% and 12%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>